Literature DB >> 9083731

Immediate recovery of psychomotor function after patient-administered nitrous oxide/oxygen inhalation for colonoscopy.

J Trojan1, B P Saunders, M Woloshynowych, H S Debinsky, C B Williams.   

Abstract

BACKGROUND AND STUDY AIMS: Previous studies have shown that patients inhaling-self-administered nitrous oxide/oxygen as a sedative/analgesic medication for colonoscopy were ready to leave the endoscopy unit on average sooner than those given conventional intravenous premedication. The aim of this study was to define the time course of recovery after nitrous oxide/oxygen sedation or intravenous opiate/benzodiazepine premedication for colonoscopy. PATIENTS AND METHODS: Consecutive colonoscopy patients were randomized to receive either a 50% nitrous oxide/oxygen mixture (n = 12), or pethidine 25-50 mg and midazolam 2.5 mg (n = 15), or no sedation (n = 10). Psychomotor function was assessed by multiple-choice reaction time, hand-eye co-ordination, and letter deletion tests before and at 15-minute intervals after colonoscopy, with the assessment carried out by an observer blinded to the sedation regime.
RESULTS: The mean duration and tolerance of the procedure were similar in the three study groups. Patients receiving nitrous oxide/oxygen mixture were judged (by clinical observation) to recover more quickly than those given conventional sedation (median 8 min, range 3- 25 min, vs. median 16 min, range 3-50 min). Recovery, as judged by a return to baseline in psychomotor function tests, was complete within 30 minutes in all patients receiving the nitrous oxide/oxygen mixture, compared to 50 minutes in those given conventional intravenous sedation.
CONCLUSIONS: The rapid recovery observed with nitrous oxide/oxygen sedation for colonoscopy suggests that it is safe for patients to travel unescorted after the procedure. Driving may also be safe soon after nitrous oxide/oxygen sedation, but this requires further clarification.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9083731     DOI: 10.1055/s-2007-1004055

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  6 in total

1.  Value of fentanyl in flexible sigmoidoscopy.

Authors:  Sanjoy Basu; Badri Krishnamurthy; Tim H Walsh
Journal:  World J Surg       Date:  2004-09       Impact factor: 3.352

2.  Nitrous oxide use during colonoscopy: a national survey of English screening colonoscopists.

Authors:  Alex J Ball; Jennifer A Campbell; Stuart A Riley
Journal:  Frontline Gastroenterol       Date:  2014-04-15

Review 3.  Entonox® inhalation to reduce pain in common diagnostic and therapeutic outpatient urological procedures: a review of the evidence.

Authors:  A Young; M Ismail; A G Papatsoris; J M Barua; J G Calleary; J Masood
Journal:  Ann R Coll Surg Engl       Date:  2012-01       Impact factor: 1.891

4.  Clinical analysis of propofol deep sedation for 1,104 patients undergoing gastrointestinal endoscopic procedures: a three year prospective study.

Authors:  Stojanka Gasparović; Nadan Rustemović; Milorad Opacić; Marina Premuzić; Andelko Korusić; Jadranka Bozikov; Tamara Bates
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

5.  Randomized controlled study of the safety and efficacy of nitrous oxide-sedated endoscopic ultrasound-guided fine needle aspiration for digestive tract diseases.

Authors:  Cai-Xia Wang; Jian Wang; Yuan-Yuan Chen; Jia-Ni Wang; Xin Yu; Feng Yang; Si-Yu Sun
Journal:  World J Gastroenterol       Date:  2016-12-14       Impact factor: 5.742

6.  Colonoscopy quality with Entonox®vs intravenous conscious sedation: 18608 colonoscopy retrospective study.

Authors:  Alexander R Robertson; Nicholas A Kennedy; James A Robertson; Nicholas I Church; Colin L Noble
Journal:  World J Gastrointest Endosc       Date:  2017-09-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.